ArticleCancer management and research2018

Cost-effectiveness analysis of adjuvant treatment for resected pancreatic cancer in China based on the ESPAC-4 trial.

Jiaxing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.